CBUS.NASDAQCibus, INC

Form 4: Cibus Inc. Director Gerhard Prante Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


Director Gerhard Prante of Cibus Inc. sold 2,300 shares of Class A Common Stock on February 18, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On February 18, 2025, Gerhard Prante, a director of Cibus Inc., sold 2,300 shares of Class A Common Stock.
  • The sales were executed at a price of $2.52 per share.
  • These transactions were carried out under a Rule 10b5-1 trading plan adopted on August 16, 2024.
  • Following the reported transactions, Prante directly owns 13,457 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

Sales by insiders are a common occurrence and are often viewed in the context of the individual's financial planning rather than a reflection of the company's prospects. Rule 10b5-1 plans are designed to allow insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

  • The sale of shares by a director could have a minor negative impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
08/16/2024Date of adoption of Rule 10b5-1 trading plan
02/18/2025Date of transaction (sale of shares)
02/19/2024Date of signature on the Form 4

Keywords

Form 4, Cibus Inc., Gerhard Prante, Class A Common Stock, Rule 10b5-1 trading plan, Director, Share Sale, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.